MASLD rates have decreased, whereas liver fibrosis and cirrhosis rates have increased among US patients with type 2 diabetes since 2017.

Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis and portal ...

Liver diseases, especially fatty liver, are rising fast, even among non-drinkers. Liver specialist Dr Saurabh Sethi shares 9 ...

Traditional cardiovascular risk assessment tools underperform among individuals with metabolic dysfunction-associated steatotic liver disease.

When The Making Of Pakeezah Was Surrounded By Dark Tragedies (Photo Credit – Youtube) Meena Kumari is a name synonymous with ...

Know the hidden link between hypertension and fatty liver disease. Learn how high blood pressure can impact your liver health ...

London: GSK plc has concluded the acquisition of efimosfermin alfa from Boston Pharmaceuticals in a USD 2 billion ...

Salmonella infections rose 92.4 per cent, from 66 patients in the first week of June to 127 by the fourth week. Read more at ...

A doctor has shared the four most common warning signs there could be something wrong with your liver - and when you need to ...

GSK completes $2 billion acquisition of efimosfermin from Boston Pharmaceuticals: London, UK Wednesday, July 9, 2025, 09:00 Hrs [IST] GSK plc announced the completion of its previ ...

Marking Guru Dutt’s 100th birth anniversary, we look back at the poetic brilliance, personal pain, and cinematic legacy of ...